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Background: Viable embryos secrete preimplantation factor (PIF), a peptide that has autocrine effects where levels
correlate with cultured embryos development. sPIF (PIF synthetic analog) promotes implantation by regulating
decidual-cells immunity, adhesion, apoptosis and enhances trophoblastic cell invasion. Herein sPIF priming effects
on non-decidualized endometrium and decidualized-stroma are investigated, assessing elements critical for
effective embryo-maternal cross-talk, prior to and at implantation.
Methods: We tested sPIF effect on human non-pregnant endometrial epithelial and non-decidualized stroma α2β3
integrin expression (IHC and flow cytometry), comparing with scrambled PIF (PIFscr-control). We examined sPIF
effect on decidualized non-pregnant human endometrial stromal cells (HESC) determining pro-inflammatory
mediators expression and secretion (ELISA) and growth factors (GFs) expression (Affymetrix global gene array). We
tested sPIF effect on HESC Phospho-kinases (BioPlex) and isolated kinases activity (FastKinase).
Results: sPIF up-regulates α2β3 integrin expression in epithelial cells, (P< 0.05) while PIFscr had no effect. In
contrast, in stromal cell cultures sPIF had no effect on the same. In HESC, sPIF up-regulates pro-inflammatory
cytokines; IL8, IL1β and IL6 expression. The major increase in GRO-α, ICAM-1 and MCP-3 expression is coupled with
same ligands secretion (P< 0.05). sPIF modulates in HESC GFs expression: up-regulates amphiregulin and
epiregulin- critical for implantation and enhances several fibroblast growth factors (FGF) relevant for decidual
function. In contrast, sPIF down-regulates major pro-proliferative ligands, betacellulin and IGF1 expression. sPIF
modulatory effect on GFs is exerted by down-regulating pro-proliferative phospho-activated MAPkinases, p-MEK1
and p-ERK (P< 0.01, P< 0.04, respectively). Stress-induced p-38-MAPK (P = 0.04) and c-Jun kinase signaling involved
MAPK8IP2 (−2.1 fold) expression decreased which protects against reactive oxygen species. Although pro-
inflammatory p-NFkB (P = 0.06) decrease was mild, its promoter TNFRS11 expression markedly (−25-fold) decreased.
In contrast, anti-proliferative phosphatases PTPRZ1 and PPP2R2C expression increased.
Conclusions: sPIF post-fertilization primes endometrial-epithelium, while during implantation creates a beneficial
pro-inflammatory milieu. PIF acts by balancing decidual pro-implantation properties while controlling excessive
pro-proliferative and inflammatory signals expression. Overall, PIF influences critical peri-implantation events in a
sequential coordinated fashion which facilitates embryo implantation.
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Embryo-maternal cross talk is essential for establishment
of normal pregnancy and such is critical at earliest stages -
post-fertilization [1-4]. At that time, contact between
embryo (segregated in the zona-pellucida) and maternal
environment is limited. The pre-implantation period
could be perceived as silent; when the maternal system is
unaware of the embryo presence. However, recent data
reported by us and by others indicates that already post-
fertilization and prior to implantation, embryo-maternal
dialogue critical for impending pregnancy develops [5-10].
Effect of numerous compounds that promote a recep-
tive endometrium was previously examined. The role
of cytokines/chemokines, integrins, and growth factors
(GFs) was tested. Specifically EGF-related compounds
have been shown to have contrasting effects. EGF for
example promotes murine implantation while blocking
decidualization in culture [11]. Further, trophoblast-
conditioned media reduces TGFβ2 and IGF1 secretion
in decidualized-cells [12].
In this context, we focused on preimplantation factor
(PIF), an embryo-specific peptide secreted by viable
mammalian embryos starting at two-cell stage and
throughout viable pregnancy, absent in non-viable
embryos [4-6,13-18]. PIF levels in culture, correlate with
embryo viability [19,20]. PIF exhibits a direct auto-
trophic effect, promotes embryo development in culture
and negates maternal serum-induced toxicity derived
from patients with history of recurrent pregnancy loss
[19,20]. PIF is expressed by the placenta and present in
maternal circulation until term. PIF acts mainly on
activated immunity creating a Th2/Th1 bias thus
modulating maternal immune system without suppres-
sion [8,21]. Similarly, in non-pregnant autoimmune
models, short-term, low-dose sPIF (synthetic PIF analog)
prevents juvenile diabetes development by restoring pan-
creatic function [22] and in a harsh neuroinflammation
model reverses inflammation while promoting neural re-
pair [23]. sPIF promotes first trimester cultured tropho-
blast cells invasion, facilitating placental engraftment
and development, while not synergizing with epidermal
growth factor (EGF), a non pregnancy–specific prolifera-
tion promoting growth factor that is expressed in the
endometrium [24]. sPIF also conditions the intrauterine
environment, particularly the sex steroid-primed human
endometrial stromal cells (HESC), and the first trimester
decidua in culture by enhancing embryo implantation
and providing support for the embryo by acting in the
first trimester decidua. sPIF effect is exerted by modulat-
ing local immunity, adhesion and controlling apoptosis
evidenced by affected genes expression and associated
tissue proteome [25].
Since PIF is already secreted shortly post-fertilization,
a 5–7 day delay exists until implantation takes place. Wequeried whether PIF can prime the endometrium during
that critical period. We also examined PIF role in affect-
ing pro-inflammatory factors secretion by HESC. sPIF
promotes trophoblast invasion- essential for proper pla-
cental development independent of EGF. Therefore sPIF
effect on endogenous (GFs) expression including EGF
and regulation by phosphorylated MAP-kinases activity
was examined. Such information establishes PIF’s critical
role in creating a pro-receptive environment for the
embryo prior and during implantation.
Herein, we examine sPIF effect on non-pregnant, non-
decidualized endometrium, evaluating α2β3 integrin
expression, a prime implantation marker [3]. Further,
sPIF effect on HESC, examines integrins and pro-
inflammatory genes expression and secretion. We also
determine sPIF effect on relevant endogenous GFs ex-
pression in HESC and down-stream pathways involved
in their regulation. Such data is relevant for understand-




Synthesis was previously described [25]. In short, synthetic
PIF analog (MVRIKPGSANKPSDD) or MVRIKPGSA
and scrambled PIF (GRVDPSNKSMPKDIA) PIFscr –
used as negative control, were produced by using
solid-phase peptide synthesis (Peptide Synthesizer;
Applied Biosystems, Foster City, CA) employing Fmoc
(9-fluorenylmethoxycarbonyl) chemistry [21,24,26]. Final
purification was carried out by reversed-phase high-
pressure liquid chromatography, and peptide identity was
verified by mass spectrometry [25].
Endometrial cell cultures
Approval by the Institutional Review Board at the Yale
University School of Medicine and St. Mary Hospital,
Waterbury, CT, was obtained to collect endometrium
and to carry out the endometrial experiments in this
study. The method was previously published [25,27].
Briefly, discarded endometrial tissues from premenopau-
sal women that undergo hysterectomies due to benign
indications (primarily myomas) were analyzed. Women
provided consent via the standard hospital consent form.
There were no anticipated risks associated with partici-
pation in this research over the risks associated with the
surgical procedure that women underwent for removal
of their uterus. After removal during hysterectomy, the
uterus was evaluated in the Department of Pathology at
Yale New Haven Hospital and in St. Mary Hospital, CT,
Dr. M. Albini. The pathologist provided a sample of dis-
carded endometrial tissue, transported to our research
laboratory for sPIF experiments. Collected endometrial
tissues 400 mg were digested with 0.1% DNAase
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sedimentation of glandular structures and separation of
ESC, the glands were purified of ESC and macrophage
contaminants were removed by incubation at 37°C in a
Falcon flask. This was followed by a second enzymatic
digestion isolating the individual endometrial epithelial
cells (EEC) from the glands for flow cytometric measure-
ments. Glands were digested with trypsin (0.25%)–EDTA
(0.03%)–DNase (0.1%) for 10 min at 37°C. Subsequently
EEC were washed with DMEM–fetal bovine serum (FBS,
2%) and filtered out through a 37 μm mesh sieve. Stro-
mal and epithelial cell dispersions were counted in a
haemocytometer and cell viability was assessed using
Trypan Blue exclusion method. ESC and EEC percent
viability was >80%. Polyclonal antibodies to vimentin
(Vm) and cytokeratin (Ck) were used to examine the
homogeneity of ESC (Vimentin+) and EEC (Cytokeratin+)
in cell smears of cellular dispersions. The maximum
cross-contamination between ESC and EEC was <1%.
[30]. Subsequently cells were cultured separately in cell
bottom plates (8 well) for 5 days in DMEM-MCDB105
medium with 10% FCS (Sigma Chemical Co., St. Louis,
MO) and for 24hrs in serum-free media containing
1–125 nM sPIF (15, or 9 aa). Epithelial and stromal were
detached with Trypsin 0.01% EDTA 1nM (10min) and
washed with PBS and cells were counted. Cells were
stained with an anti-α2β3 integrin mAb (clone SSA6,
1:100) and an anti-mouse-FITC conjugate (1:100). α2β3
integrin expression was then determined by flow cytome-
try. A negative control with nonspecific IgG isotype-
matched mAb (Dako, Carpinteria, CA) and an anti-
HLA-I mAb (clone w6/32, 1:100) were introduced in
each determination (n = 5). α2β3 integrin concentrations
Mean±SEM) were expressed as percentage of basal anti-
gen expression in epithelial cells without sPIF. P< 0.05
was considered statistically significant. The sPIF-induced
effect was compared to cells exposed to BSA 2%, 10%
FCS, or PIFscr 1-500nM used as controls.
In other experiments endometrial cells were isolated
and resuspended in RPMI-1640, grown to confluence,
leucocyte free (<1%). After reaching confluence, cells
were decidualized using 10-8 M estradiol and 10-7 M of
the synthetic progestin analogue R5020 (Du Pont/New
England Nuclear Products, Boston, MA). Cells were
switched to defined medium containing insulin, trans-
ferrin, and selenium, (Collaborative Research, Inc.,
Waltham, MA) with 5 μM trace elements (GIBCO),
and 50 μg/ml ascorbic acid (Sigma-Aldrich) and treated
overnight with sPIF (100 nM) or vehicle only. The media
and tissues were collected and frozen at −80°C. Products
secreted into the media were analyzed using the bead-
analysis kit (Bio-Rad, CA) and the lysates phospho-
proteins by BioPlex kit (Bio-Rad, CA) in triplicate deter-
mining (Mean±SEM) activity, following the manufacturerinstructions. sPIF and PIFscr effect (10 nM- 10mg/ml) on
isolated kinases was tested by using the proprietary Fastki-
nase method analyzing direct action of peptides generat-
ing IC50 data, XlFit by software (MDSPS, Bothell, WA).
Microarray analysis
Total RNA was extracted from each cell culture as
previously reported [25]. Analysis of HESC ± sPIF 100
nM (n = 3/group) was carried out by using Affymetrix
(Santa Clara, CA) U133 Plus 2.0 Array (18,400 human
genes), followed by fluorescence labeling and
hybridization with Fluidics Station 450 and optical
scanning with GeneChip Scanner 3000 (Affymetrix) at
W. M. Keck Foundation Biotechnology Resource La-
boratory, Yale University, New Haven, CT. Raw data
were analyzed by GeneSpring software (Agilent, Santa
Clara, CA), normalized for interchip and intrachip
variation to eliminate false-positive results. Microchip
was analysed by National Institutes of Health’s ImageJ
image-analysis software (http://rsb.info.nih.gov/ij).
P< 0.05 and two fold change was considered statisti-
cally significant. See Additional file 1: Table S1
describes signal intensity and P value associated with
gene detection.
Statistical analysis
Data was analyzed using Meta-plex software, t-test; sig-
nificance was set at p< 0.05. The Bioplex data was
analyzed by using log transformed data, followed by
ANOVA P< 0.05. For gene experiments the data were
first analyzed using Student’s t-test with P< 0.05 results
followed by fold change testing with a cutoff equal or
>2-fold reported.
Results
sPIF up-regulates cultured endometrial epithelial cells
α2β3 integrin
sPIF effect on endometrial receptivity was investigated
modeling the early luteal phase at a stage when circulat-
ing estrogen and progesterone levels are low (no direct
embryo-endometrial contact). For this end, primary epi-
thelial and stromal endometrial cells cultured for five
days reaching confluence were used, exposing them to
sPIF for 24hrs. Two different versions of sPIF were
tested, both found in the embryo culture media, having
the same core 9 first aminoacids. It was found that in
epithelial cell cultures both, sPIF(15aa) and sPIF (9aa) at
low physiologic concentrations increased α2β3 integrin,
an important marker of endometrial receptivity, up
to 4-fold in a dose-dependent manner (P< 0.01).
(Figure 1a,b) Two different complimentary modalities of
analysis were conducted; first qualitative analysis using
an anti-α2β3 integrin-antibody carrying out staining of
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Figure 1 sPIF promotes endometrial receptivity by
up-regulating α2β3 integrin. Endometrial epithelial cells were
isolated and cultured for 5 days in presence of FCS followed by
24hrs in serum-free media containing 1–125 nM sPIF (15, or 9 aa). At
the end of culture cells stained with specific antibody and α2β3
integrin expression was then determined by flow cytometry.
Nonspecific IgG isotype served as negative control. a) PIF15 promotes
α2β3 integrin in a dose dependent manner as compared with
scrambled PIF 125nM or 2%BSA, effect was not significant. b) PIF9
promotes endometrial-α2β3 integrin in a dose dependent manner
as compared with 2%BSA, control. Data expressed as (Mean± SEM.)
percent change in basal antigen expression in epithelial cells as
compared to negative controls. Data are representative of three
different experiments with similar results (ANOVA, *P< 0.05).
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cytometry (FC). The data showed that sPIF is most ef-
fective at low concentrations similar to physiologic
range found in pregnancy. Significant stimulatory effect
was noted with both ligands already at a low 1nM con-
centration, effect being dose dependent. sPIF specificity
was confirmed since PIFscr (scrambled peptide, same
amino acids as sPIF but in different order), bovine
serum albumin (2% BSA), or 10% FCS effect tested in
parallel and used as controls, had no effect. Importantly,
the increase seen in α2β3 integrin in epithelial cells
was not replicated by exposure to primary culture of
non-decidualized stromal cells when tested with two
independent methods (not shown). Overall, these experi-
ments indicated that sPIF promotes a critical pro-
implantation marker in uterine epithelium independently
of sex-steroid exposure.sPIF effect on integrins in HESC
The endometrial epithelial cells are the site where
embryo-derived signaling primes post-fertilization to pro-
mote implantation. sPIF increased α2β3 integrin in epithe-
lial cells in primary culture and not in non-decidualized
stromal cells. Therefore, we inquired whether sPIF also
has similar effect on integrins in HESC, which are estro-
gen and progestin-induced decidualized stromal cells.
sPIF in HESC as expected, does not affect ITGB3 expres-
sion the gene that encodes for α2β3 integrin, however,
sPIF promotes ITGA2- (1.96 fold), a platelet membrane
integrin. An increase in ITGB1(1.92, fold) a fibronectin
receptor which is activated by Netrin-4 involved in
vascular development was also noted. In contrast, sPIF
down-regulated ITGA9 (−2.1 fold), expression, a recep-
tor for VCAM1, cytotactin and osteopontin which binds
to VEGF and promotes adhesion and cell migration.
Thus, we showed that sPIF effect is dynamic and modu-
lates the endometrium in a different manner, dependent
on the evolving stage of embryo-maternal cross-talk at
pre-and during implantation period.
sPIF promotes pro-inflammatory mediators secretion
by HESC
In line with the described beneficial pro-inflammatory
effects of sPIF on HESC genes expression, we examined
whether they are also translated into changes in secreted
pro-inflammatory mediators- relevant for uterine environ-
ment conditioning. There was a significant up-regulation
of major inflammatory interleukins, IL8 (82-fold) IL1β
(7-fold) and IL6 (10.7-fold). The increase in intercellular
adhesion molecule 1, (ICAM-1, CD54) gene expression
was coupled with ligand secretion, a leukocyte adhe-
sion protein (integrin alpha-L/beta-2). The chemokines
(growth-related oncogene-α (GRO-α, CXCL1) gene ex-
pression chemotactic for neutrophils, was coupled with
protein secretion. The monocyte chemotactic protein-1
(MCP-1, CCL7) gene expression was also coupled with
protein secretion. (Figure 2a,b) We show that sPIF-
induced gene expression leads to pro-inflammatory ligands
secretion favorably conditioning the uterine environ-
ment for embryo implantation.
sPIF up-regulates amphiregulin, epiregulin and FGFs
expression in HESC
We reported that sPIF did not synergize with exogen-
ously added EGF in promoting trophoblast invasion.
Since EGF is a member of a major proliferation-
promoter family expressed by HESC, we examined sPIF
effect on EGF and related GFs expression. Amphiregulin
and epiregulin genes expression increased which encode
proteins that promote decidual and cultured embryos
development. In contrast, pro-proliferative betacellulin





















































Figure 2 sPIF-induced promotion of pro-inflammatory genes is
coupled with their secretion. HESC were cultured in presence with
100 nM sPIF for 24 hours. Triplicate cells were extracted and global
mRNA was.analyzed (Affymetrix). Gene expression >3 fold was
considered significant. Culture media of HESC was collected and
pro-inflammatory ligands was analyzed using ELISA. a) sPIFpromotes
mRNA expression of pro-inflammatory cytokines and adhesion
molecules as compared to controls. (b) PIF promotes inflammatory
cytokine and chemokine secretion by HESC, P< 0.05. The increase in
gene expression was confirmed by increased secretion into the
media.
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(heparin binding) and EGF gene itself or its receptor
expression was not affected. Significantly, increased
expression of several fibroblast growth factors (FGF)
was observed (Table 2). sPIF exerts a highly selective
modulatory effect on HESC, balancing decidual pro-













iosPIF modulates GFs by down-regulating p-MAPK and
up-regulating phosphatases expression
Since sPIF modulates GFs in HESC, we aimed to deter-
mine whether it is exerted by regulation of downstreamTable 1 PIF modulates growth factors to promote
endometrial receptivity
Up-Regulated Down-Regulated
Amphiregulin 8.1 Betacellulin 9.5
Epiregulin 11.1 IGF1 2.2
TGFβ2 1.6
HESC Fold Change in Gene Expression.transcription factors. Kinases added a phosphate mol-
ecule (serine, thrionine, or tyrosine) are activated. sPIF
markedly down-regulates critical transcription factors
involved in proliferative pathways (Figure 3a,b,c). A
number of activated-kinases activity involved in MAPK
pathway decreased; two proliferation promoters; ERK-
activator kinase (p-Thr202, Tyr204) -ERK1/2, (P< 0.01)sP
Figure 3 sPIF down-regulates activated p-MAPK involved in
HESC proliferative pathway. HESC were cultured in presence of
100nM sPIF for 24 hours at the end of culture lysates phospho-
proteins were analyzed by using BioPlex kit in triplicate determining
(Mean+/−SEM), P< 0.05. a)p-MEK-1 b) p-ERK1,2, c) p-p38MAPK. The
decrease in all three kinases was marked as compared to PBS
control.
Barnea et al. Reproductive Biology and Endocrinology 2012, 10:50 Page 6 of 9
http://www.rbej.com/content/10/1/50which was followed downstream by a major decrease in
p-MEK1 (p-Ser 218, Ser 222), (P< 0.04). In addition
to the decrease in TGFβ2 expression, p-38-MAPK
(p-Thr180, Tyr182), (P< 0.04) also decreased, involved
in response to stress stimuli. There was also a signifi-
cant decrease in MAPK8IP2 (−2.1 fold) (MAPK8 inter-
acting protein-2) expression which encodes a scaffold
protein that mediates c-Jun amino-terminal kinase sig-
naling pathway, protecting against reactive oxygen spe-
cies. The mild decrease in pro-inflammatory p-NFkB
(P = 0.06) was accentuated with a major decrease in
TNFRS11 expression, (−25-fold) and FAS (−3.3 fold)
major NFkB activators, while p-IKB, and p-AKT were
not affected by sPIF. Upon examining associated
phosphatases gene expression that inactivate kinases,
it was found that the phosphatases PTPRZ1 (phospha-
can, 5.5-fold) which interacts with P53-a major prolif-
eration controller, and PPP2R2C (2.9-fold) increased,
both of which inhibit MAPK and proliferative path-
ways. Thus sPIF has a dual coordinated effect on both
kinases and phosphatases. In addition, these pathways
are directly involved in down-regulation of both prolif-
eration and inflammation promoting pathways in










































Figure 4 sPIF does not directly affect MAPK activity. sPIF at different co
substrate determining IC50 values. In all tested enzymes, sPIF did not interfesPIF effect on MAPK does not involves their catalytic site
We found that sPIF modulates differentially endogenous
GFs expression and this is associated with regulation of
MAPK pathways. To examine whether sPIF has a direct
effect on MAP kinases enzymes catalytic activity, the
Fastkinase method was used to evaluate a given ligand
effect on the enzyme activity itself as part of a panel. In
contrast to the marked inhibitory effect on phosphopro-
teins expression seen in HESC, sPIF did not affect re-
combinant kinases involved in the MAPK pathway
ERK1,2, MEK-1, p-38-MAPK, or NFkB activity in vitro
(Figure 4). sPIF also did not affect directly the EGF pro-
tein tyrosine kinase activity, the down-stream activator
of the growth factor. Thus, sPIF down-stream inhibitory
effects on proliferative elements in HESC is exerted by
down-regulation of pro-proteins involved in the MAPK
pathway, which is independent of a direct action on the
catalytic site of these enzymes.
Discussion
PIF is a specific embryo-derived biomarker which,
through autocrine effects, supports embryo development
and survival starting prior implantation. In addition,
sPIF promotes embryo receptivity creating a favorableb)
d)








































ncentrations was added to purified enzymes in presence of enzyme
re with the enzyme activity. a) MEK-1 b) ERK-1, c) ERK-2. d) p38-MAPK.
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(HESC) and first trimester decidua [26].
We herein demonstrate that sPIF has an evolving
coordinated pro-receptive effect on uterine environment
favoring embryo implantation and development. This
is evidenced by the noted increase in α2β3 integrin -
critical pro-implantation marker in non-pregnant endo-
metrial epithelial cells. In HESC- an implantation model
sPIF modulates integrins expression and increases pro-
inflammatory ligands expression and secretion- creating
a pro-receptive uterine milieu. Effect of sPIF on HESC
supports implantation by increasing amphiregulin, epire-
gulin and FGFs while reducing proliferation promoter,
betacellulin expression. Mechanistically, sPIF modulating
effect on GFs involves p-MAPK inhibition coupled with
increased phosphatases expression.
To demonstrate our observations we used a multi-
faceted approach. Specifically, we: 1) Tested effect of
sPIF on primary endometrial and stromal cell cultures
α2β3 integrin. 2) Analyzed sPIF effect in HESC on
integrin expression. 3) Correlated effect of sPIF on
HESC pro-inflammatory genes expression with secreted
ligands. 4) Examined sPIF effect on endogenous GFs
expression in HESC. 5) Determined sPIF effect on GFs-
related phospho-kinases and associated phosphatases in
HESC.
Prior to this study, it was not fully established how
early embryo-maternal cross talk is initiated. We herein
report for the first time, that PIF, an embryo-specific
compound, has an important evolving role in uterine
priming prior embryo arrival to the uterus. The sPIF-
induced up-regulation of α2β3 integrin, a critical im-
plantation marker in primary epithelial cells correlates
with window of implantation [3]. Consequently, sPIF ef-
fect already initiates post-fertilization when the embryo
is segregated within the fallopian tube and no direct
contact between embryo and uterus exists. The sPIF-
induced increase in α2β3 integrin is independent of es-
trogen and progesterone exposure since steroids were
not added in culture when PIF itself is added. Such is
compatible with the post-fertilization period when circu-
lating progesterone levels are low. Therefore PIF-
induced endometrial priming precedes that induced by
progesterone and it evidences that an embryo-specific
signal is needed for effective endometrial-priming. Both
embryo-secreted PIF peptides15aa and shorter (9aa) are
present in embryo culture media [21,26] had similar pro-
moting effect which supports their pro-receptive proper-
ties. The 15aa is the dominant peptide secreted by the
embryo therefore it was used in subsequent experiments.
Lack of effect of scrambled PIF and negative controls
tested in parallel confirmed sPIF specificity. Notably, sPIF
did not affect primary stromal cells (non-decidualized)
evidencing that increased α2β3 integrin expression isinduced only in epithelial layer, first contact between
embryo and endometrium.
The HESC model was chosen since it mimics the im-
plantation decidua. Here, stromal cells conditioned by
sex steroids replicate mid-luteal phase when circulating
progesterone and estrogen peak and implantation takes
place. Precise mechanisms involved in decidualization
have not been previously fully characterized [31]. In
HESC sPIF affects integrins involved in inflammation
and vascular pathway [32] acting on Netrin-4, an integ-
rin receptor [33] while the gene specific for α2β3 integ-
rin expression is not affected. Increase in integrin A2
may protect against fetal loss due to platelet membrane
polymorphism [34]. The shift between pre-and implant-
ation with respect to integrin expression reflects PIF
evolving role at this critical period.
sPIF modulates HESC genes and several associated
proteins. Whether such leads to pro-inflammatory
ligands secretion creating a favorable uterine milieu was
examined. sPIF markedly increases several critical pro-
inflammatory genes expression which in the innate arm
of immunity, is involved in monocytes recruitment and
in adaptive immunity in leukocyte recruitment and adhe-
sion [9]. Endometrial-biopsy performed in IVF patients
also increased local macrophage presence, GRO-α and
other inflammatory mediators and led to improved preg-
nancy outcome [35]. We now document that such an in-
crease in pro-inflammatory ligands can also be induced
in HESC by PIF an embryo-specific signal.
Sex steroids, especially estrogen, condition endomet-
rial stromal cells towards decidualization by exerting
potent-proliferative effects. sPIF promotes cultured
trophoblastic cells invasion in culture, not amplified by
EGF, a potent non-pregnancy specific growth factor. The
major decrease noted in the expression of betacellulin, a
promoter EGF, supports the anti-proliferative role of
PIF. Endogenous GFs expression is significant in HESC,
therefore it is remarkable that sPIF increases amphiregu-
lin and epiregulin, factors that support embryo matur-
ation and decidual development [36]. This is of
importance since amphiregulin is not a progesterone-
dependent uterine gene [37]. sPIF promoted decidual
fibroblast growth factors (FGFs) expression - some of
them are novel and such is relevant since the stroma is
composed of fibroblasts [31]. FGFs affect embryo implant-
ation and support improved endometrial-trophoblastic
interaction [38,39]. Thus sPIF shifts the decidua from a
proliferative to a receptive mode needed for implantation.
GFs proliferative effects are exerted through activated
phospho-kinases. The consistent and profound down-
stream inhibition induced by sPIF on HESC MAPK pro-
proliferative pathways support a targeted effect on GFs
expression. The decrease in p-MEK1 a kinase up-stream
of p-ERK1 might have led to the down-stream inhibition
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duction in p-38-MAPK inhibits TGFβ2-induced signal-
ing and the decrease in c-Jun expression reflects anti-
inflammatory effects of sPIF. Inhibition of the NF-kB
pathway directly interferes with the pro-inflammatory
TNF-induced signaling [41]. Based on our results sPIF
inhibitory action on MAPK is independent of their cata-
lytic site. sPIF increased kinase-inactivating phosphatases
the first enzyme removes Ser/Thr phosphate [42] while
PTPRZ1, a tyrosine phosphatase, has differentiating ef-
fect in the nervous system, and was not previously
reported in the decidua [43,44]. Through coordinated ef-
fect on p-MAPK and phosphatases PIF shifts the endo-
metrial stroma from a proliferative pro-inflammatory
into a receptive environment critical for embryo survival.
It is recognized that in order to implant, the embryo
induces specific changes in the endometrium absent in
non-pregnant decidua [45,46]. Trophoblast-conditioned
media affects a large number of decidual genes where
specific factor(s) involved were not identified [12]. Role
of various non-embryo specific factors involved in decid-
ual function was also recently reviewed [2]. We focused
herein on PIF as a single embryo-specific viability signal
and its effect on the endometrium, demonstrating wide-
range regulatory effects.
The strength of this study is use of sPIF in two com-
plementary models, examining post-fertilization endo-
metrial environment and sex steroid-conditioned stromal
cells- implantation model. Also, testing critical integrins,
pro-inflammatory mediators secretion, endogenous GFs
expression and mechanistically examination of activated
kinases and phosphatases involved in their regulation.
The study is limited since observations in culture do not
necessarily reflect the in vivo condition.
Conclusions
Our findings support the premise that modulation of
maternal uterine environment is significantly embryo-
driven. Modulation starts shortly post-fertilization and
PIF plays a critical evolving role amplified during im-
plantation. By priming the uterus PIF creates a receptive
milieu for embryo development which may have signifi-
cant therapeutic implications.
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